I migliori medici per il trattamento di Tumore del testicolo - TOP-104 medici

Oltre 20 anni di specializzazione in immunoterapia del cancro e terapie mirate per il cancro ai testicoli presso l'Anadolu Medical Center – il Prof. Karagöz combina una ricerca approfondita con la pratica clinica.

• Professore presso l'Università Okan di Istanbul – forma futuri oncologi
• Ha pubblicato oltre 40 articoli di ricerca nel trattamento del cancro
• Ex capo dell'oncologia medica presso l'Ospedale di Formazione GATA Haydarpaşa
• Specializzato in biologia dei tumori e approcci basati sull'immunologia

Il professor Zafer Gülbaş — ematologo-oncologo, fondatore e direttore del Centro Trapianti di Midollo Osseo dell'Anadolu Medical Center, che è tra i più grandi in Europa.

Perché i pazienti scelgono e si fidano del Dr. Gülbaş:

• Ha creato il Centro Trapianti di Midollo Osseo dell'Anadolu "da zero"; nel centro sono stati eseguiti 3.000+ trapianti (dal 2010).
• 81% di successo nei trapianti autologhi — un alto tasso secondo i dati del centro.
• Formazione internazionale: tirocini e lavoro nei centri leader — Hadassah (Israele), Fred Hutch e MD Anderson (USA), Princess Margaret (Canada).
• 260+ pubblicazioni scientifiche e 5.000+ citazioni — confermano il significativo contributo del professore nella trapiantologia.
• La clinica Anadolu — partner ufficiale di Johns Hopkins Medicine International, che garantisce accesso a protocolli internazionali, consili medici e controllo di qualità.
• Gestisce i casi più complessi: leucemie, linfomi, anemia aplastica, coagulopatie (disturbi della coagulazione).

La Dott.ssa Eda Tanrikulu è specializzata in oncologia medica e chemioterapia presso il Centro Medico Anadolu, con una vasta formazione ed esperienza nel settore.

• Ha completato la formazione in oncologia medica presso l'Università di Marmara
• Ha ricoperto il ruolo di ricercatrice principale in studi clinici internazionali
• Si è classificata terza in Turchia nell'esame di specializzazione minore
• Lavora presso il Centro Medico Anadolu dal 2021

17 anni di esperienza in oncologia clinica – Il Dott. Solak è specializzato nel cancro ai testicoli, oltre ad altri casi complessi di oncologia, presso l'Hisar Hospital Intercontinental.

• Formato presso l'Istituto di Cancro dell'Università di Hacettepe
• Borsa di studio presso l'MD Anderson Cancer Center dell'Università del Texas
• Si occupa di cancro al seno, ai testicoli, alle ovaie e altri tumori

Il medico è un oncologo urologico specializzato in chirurgia minimamente invasiva, ricostruzione della neovescica e cancro urologico presso l'Anadolu Medical Center. Con una laurea presso l'Università di Istanbul e una residenza in urologia presso l'Università di Marmara, il medico è stato riconosciuto con diversi premi, tra cui il Premio di Incoraggiamento alla Scienza per gli Studenti di Residenza nel 2008 e il Premio per la Presentazione Accademica Giovane nel 2012.<\/p>

Il medico è membro del Consiglio Esecutivo dell'Associazione di Urooncologia e segretario del Gruppo di Ricerca sui Tumori della Vescica. Inoltre, il medico è membro della Rete Internazionale del Cancro della Vescica, dell'Associazione Europea di Urologia e dell'American College of Surgeons.<\/p>

Dr. Gorkem Turkkan is a radiation oncologist at Hisar Hospital Intercontinental in Istanbul. He has successfully completed over 2,500 radiotherapy sessions using MR-Linac technology. Dr. Turkkan focuses on MRI-guided radiotherapy and stereotactic treatments for various cancers. He conducted clinical research on proton therapy at the MAASTRO Clinic in the Netherlands.

• Specializes in prostate, breast, lung, and head and neck cancer treatments.
• Uses VMAT and IMRT techniques to target tumors with precision.
• Maintains membership in the European Society of Radiotherapy and Oncology.
• Works at a JCI-accredited hospital serving 500,000+ patients annually.

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.

Il Prof. Merimsky dirige l'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Centro Medico Sourasky con un focus specializzato sui tumori rari.

• Oltre 25 anni dedicati all'oncologia dei sarcomi e dei tumori rari
• Formazione in fellowship presso l'Institut Gustave Roussy – il principale centro per i sarcomi in Europa
• Membro della facoltà di sarcoma dell'ESMO e di gruppi di ricerca internazionali
• Ha pubblicato ampiamente su nuovi trattamenti per i sarcomi

Il Dott. Sarid dirige il dipartimento di oncologia, urologia e radioterapia presso l'Ichilov Medical Center, apportando un'ampia esperienza nel trattamento del cancro ai testicoli.

• Specializzato in urologia oncologica presso l'Università di Oxford
• Ricercatore principale di studi clinici sulle terapie oncologiche
• Ha pubblicato oltre 30 articoli sul trattamento del cancro
• Membro di società oncologiche europee e americane

Dr. Rana Niftaliyeva is an oncologist-mammologist at the Biological Medicine Integrative Health Center in Baku. She specializes in breast cancer treatment and precancerous mammary gland diseases. Dr. Niftaliyeva has participated in medical conferences across Azerbaijan, Germany, and Turkey. She focuses on integrative approaches to cancer care.

• Treats large breast cysts using non-surgical aspiration techniques.
• Provides mistletoe therapy and high-dose vitamin C cancer treatments.
• Manages side effects of chemotherapy and radiation through supportive care.
• Performs biopsies and hormonal therapy for various oncological conditions.

Education/Academic Experience

Apr 1995 – Oct 2001                Medical School of Aristotle University of Thessaloniki, Greece

Mar 2007                                   IELTS Certificate (Overall Band Score 7.5)

Feb 2011                                    CCST in Urology, Aristotle University of Thessaloniki, Greece

June 2012                                  Fellow of the European Board of Urology (FEBU)

Sept 2014                                  Fellow in Andrology/Reconstructive Surgery (Mr Giulio Garaffa,         UCLH / Mid-Essex)

Apr 2016                                   Fellow of the Royal College of Surgeons of England (FRCS Eng)

Oct 2018                                   Honorary Senior Lecturer St Andrews University

Sep 2019                                   Urology ChM Tutor in Andrology and Minimally Invasive Surgery (MIMS) University of Edinburgh

Aug 2020                                  European Union Expert Panel Member of in vitro Medical Devices (EU EXPAMED)

Current and Previous appointments

Current appointment

May 2022- Present         Consultant Urologist German Oncology Centre, Limassol, Cyprus

Previous appointments

Nov16- May 2021       Consultant Urological Surgeon Victoria/ Queen Margaret Hospital Fife, Scotland.

Nov 2012 - Oct 2016      Consultant Urologist Broomfield Hospital, Mid-Essex Hospitals Trust 

Jan 2011 - Oct 2012      Urology Clinical Research Fellow, Spelialist Registrar Level), Bristol Royal Infirmary, United Bristol Hospitals Trust

Dec 2009 -Dec 2010      Urology Resident G. Gennimatas Hospital, Aristotle University of Thessaloniki

Duties

• Performing routine and major Penile / Urethral Reconstruction as well as Core Urology procedures twice weekly at Victoria and Queen Margaret Hospitals (Green light prostatectomy, Urolift Service lead, Prostate template biopsies, General urology)

Consultant Urologist providing and supervising the services of andrology and urethral reconstruction surgery. Also covering a general urology one stop outpatient clinics three times per week (Victoria and Queen Margaret Hospitals).

Participation in once weekly local cancer and once monthly specialist male uro-genital reconstruction MDT meetings (Honorary contract at the Western General Hospital, Edinburgh) as well as grand ward rounds.

Undergraduate student trainer and member of examiners panel at St Andrews University, Scotland.

Participation in 1:9 on call Urology Consultant rota.

Research

• Victoria Hospital, Kirkcaldy (NHS Fife) lead investigator. A prospective, multicentre study with subgroup randomisation into MRI-U/S image fusion guided prostate biopsies and routine transrectal U/S guided biopsies.  (MULTIPROS Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A pragmatic multicentre randomised superiority trial of open urethroplasty versus endoscopic urethrotomy. (OPEN Study)
•  
• Broomfield Hospital (MEHT) sub-investigator. A Multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones. (TISU
• Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Randomised Controlled Trial of the Use of Drug Therapy in the Management of Symptomatic Ureteric Stones in Hospitalised Patients. (SUSPEND Study)
•  
• Bristol Royal Infirmary sub-investigator. A Multicentre Prospective Single Arm Intervention Trial Evaluating Focal Therapy using High Intensity Focused Ultrasound (Sonablate 500) for Localised Prostate Cancer. (HIFU INDEX Study)
•  
• Bristol Royal Infirmary sub-investigator, A Randomised Controlled Trial to Determine the Effect of Decapeptyl on Reduction of Prostate Volume Pre-Radiotherapy Compared with Standard Therapy (Zoladex). (EDVART Study)

Teaching Experience

Fife Simulation BPH Course Fascilitator (Scottish Urology Training Programme, Queen Margaret Hospital, Dumfermline Fife)

Urology Simulation boot camp Faculty member (St James's University Hospital, Leeds)

General Practitioner Urology Training Programme Fascilitator (ScotGem)

Objective Structured Clinical Examination (OSCE) assessor (St Andrews University Medical School)

Teaching (case-based discussions) and trainee supervision in theatres (East Anglia / East of   Scotland Deaneries trainees)

FY1 Doctors Urology teaching Bristol Royal Infirmary (University Bristol Hospitals Trust)

Undergraduate teaching of medical students in General Hospital of the city of Drama, Greece

Anatomy, Physiology and First Aid to Undergraduate nursing students

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Abdullah Sakin is a medical oncologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in treating complex cancers, including lung, breast, and gastrointestinal malignancies. Dr. Sakin previously served as the Head of the Medical Oncology Department at Yüzüncü Yıl University. He also held a leadership role at Prof. Dr. Cemil Taşçıoğlu City Hospital.

• Provides immunotherapy, biological therapy, and hormone treatments for various cancer types.
• Treats rare and difficult conditions like thymoma, chordoma, and Ewing's sarcoma.
• Performs PET-CT scans and comprehensive oncological check-ups for men and women.
• Uses JCI-accredited facilities with systems like TrueBeam STx and Halcyon for treatment.

Il medico dirige il Dipartimento di Urologia e trapianto di rene presso il Centro Medico Teknon a Barcellona, Spagna, con oltre 30 anni di esperienza. Specializzandosi in uro-oncologia e trapiantologia, il medico ha supervisionato oltre 500 operazioni di successo, concentrandosi su patologie del sistema urogenitale utilizzando metodi minimamente invasivi, inclusi interventi laparoscopici e assistiti da robot.<\/p>

Il medico è particolarmente noto per la sua esperienza nel trattamento del cancro alla prostata e utilizza il sistema robotico Da Vinci per procedure chirurgiche innovative. Inoltre, il medico tratta patologie congenite nei bambini come il criptorchidismo ed è membro della Confederazione Urologica Americana, dell'Associazione Urologica Spagnola e della Società Europea di Urologia.<\/p>

Dr. Sefik Igdem is a radiation oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating head, neck, and prostate cancers. He currently serves as a Professor at Demiroğlu Bilim University. Dr. Igdem uses Truebeam STx and Halcyon systems for accurate radiotherapy.

• Specializes in conformal treatments for complex tumor cases.
• Treats various conditions including lung, breast, and brain tumors.
• Practices at a JCI-accredited hospital that serves 200,000 patients annually.
• Completed his radiation oncology training at the Istanbul University Cerrahpaşa Faculty.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).